FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)
CUSIP: 31189P102
Q3 2016 13F Holders as of 30 Sep 2016
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 122,342,805
- Total 13F shares
- 19,481,982
- Share change
- +5,411,248
- Total reported value
- $60,781,000
- Price per share
- $3.12
- Number of holders
- 36
- Value change
- +$17,053,469
- Number of buys
- 17
- Number of sells
- 18
Quarterly Holders Quick Answers
What is CUSIP 31189P102?
CUSIP 31189P102 identifies FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 31189P102:
Top shareholders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
3.5%
|
4,307,485
|
$7,323,000 | — | 30 Jun 2016 | |
| Polaris Venture Management Co. V, L.L.C. |
13F
|
Company |
2%
|
2,473,186
|
$4,204,000 | — | 30 Jun 2016 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
1.8%
|
2,257,920
|
$3,838,000 | — | 30 Jun 2016 | |
| Redmile Group, LLC |
13F
|
Company |
1.2%
|
1,502,180
|
$2,554,000 | — | 30 Jun 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.54%
|
657,573
|
$1,118,000 | — | 30 Jun 2016 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.41%
|
500,000
|
$850,000 | — | 30 Jun 2016 | |
| Belmont Global Advisors, Inc. |
13F
|
Company |
0.33%
|
400,000
|
$680,000 | — | 30 Jun 2016 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
394,537
|
$671,000 | — | 30 Jun 2016 | |
| Board of Trustees of The Leland Stanford Junior University |
13F
|
Company |
0.24%
|
291,067
|
$495,000 | — | 30 Jun 2016 | |
| Lombard Odier Asset Management (USA) Corp |
13F
|
Company |
0.21%
|
256,426
|
$436,000 | — | 30 Jun 2016 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.15%
|
180,700
|
$307,000 | — | 30 Jun 2016 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.15%
|
178,647
|
$304,000 | — | 30 Jun 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
108,029
|
$183,000 | — | 30 Jun 2016 | |
| Telemetry Investments, L.L.C. |
13F
|
Company |
0.07%
|
85,000
|
$144,000 | — | 30 Jun 2016 | |
| Emerald Acquisition Ltd. |
13F
|
Company |
0.07%
|
80,604
|
$137,000 | — | 30 Jun 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
0.06%
|
75,572
|
$128,000 | — | 30 Jun 2016 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.06%
|
68,444
|
$117,000 | — | 30 Jun 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
35,966
|
$61,000 | — | 30 Jun 2016 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
28,320
|
$48,000 | — | 30 Jun 2016 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.02%
|
25,531
|
$43,000 | — | 30 Jun 2016 | |
| Nationwide Fund Advisors |
13F
|
Company |
0.02%
|
22,578
|
$38,000 | — | 30 Jun 2016 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.02%
|
22,000
|
$37,000 | — | 30 Jun 2016 | |
| TFS CAPITAL LLC |
13F
|
Company |
0.02%
|
20,925
|
$36,000 | — | 30 Jun 2016 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.01%
|
18,252
|
$31,000 | — | 30 Jun 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
17,792
|
$30,000 | — | 30 Jun 2016 | |
| Creative Planning |
13F
|
Company |
0.01%
|
17,000
|
$29,000 | — | 30 Jun 2016 | |
| Hochman Cole Investment Advisors, Inc. |
13F
|
Company |
0.01%
|
11,005
|
$19,000 | — | 30 Jun 2016 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0.01%
|
7,750
|
$13,000 | — | 30 Jun 2016 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
0%
|
5,728
|
$10,000 | — | 30 Jun 2016 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
5,200
|
$9,000 | — | 30 Jun 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0%
|
4,327
|
$7,000 | — | 30 Jun 2016 | |
| Acrospire Investment Management LLC |
13F
|
Company |
0%
|
4,140
|
$7,000 | — | 30 Jun 2016 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0%
|
4,030
|
$7,000 | — | 30 Jun 2016 | |
| Walleye Trading LLC |
13F
|
Company |
0%
|
1,100
|
$2,000 | — | 30 Jun 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,030
|
$2,000 | — | 30 Jun 2016 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,000
|
$2,000 | — | 30 Jun 2016 | |
| D.A. DAVIDSON & CO. |
13F
|
Company |
0%
|
720
|
$1,000 | — | 30 Jun 2016 |
Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q3 2016
As of 30 Sep 2016,
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,481,982 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, FMR LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., Polaris Venture Management Co. V, L.L.C., Redmile Group, LLC, VANGUARD GROUP INC, EcoR1 Capital, LLC, Board of Trustees of The Leland Stanford Junior University, BRIDGEWAY CAPITAL MANAGEMENT INC, and Lombard Odier Asset Management (USA) Corp.
This page lists
36
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2016 vs Q2 2016 Across Filers
Q2 2016 holders
37
Q3 2016 holders
36
Holder diff
-1
| Investor | Q2 2016 Shares | Q3 2016 Shares | Share Diff | Share Chg % | Q2 2016 Value $ | Q3 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.